ProGnosis Biotech

ProGnosis Biotech is an innovative biotechnology company, specialized in developing and manufacturing next-generation immunoassays for food & feed safety and clinical diagnostics. With headquarters in Larissa, Greece, and additional offices in Spain, Serbia, Poland, France, Italy, and China, ProGnosis Biotech is an export-oriented enterprise. Leveraging our extensive distribution network, we successfully export ELISA kits and Lateral-flow tests to more than 50 countries worldwide. Our unwavering commitment to excellence ensures that we consistently deliver high-quality products. To guarantee the utmost standards, we actively engage in monthly Proficiency Tests held in the UK, France, Germany, Italy, and the US. Furthermore, ProGnosis Biotech...

Biotechnology,food quality,food safety,life science,elisa,lateral flow,pcr,milk adulteration,mycotoxins,enzymatic food analysis,natural toxins,immuno-assay development,aflatoxins,medical diagnostics,covid tests,rapid antigen tests,rapid antibody tests,environmental surface testing,self test,and home test

Prognosis biotech operates in the Biotechnology research industry.

Prognosis biotech's revenue is 11m - 100m

Prognosis biotech has 51 - 200 employees.